What are the typical presentation and treatment of impetigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Impetigo: Presentation and Treatment

Topical mupirocin is the first-line treatment for localized impetigo, applied 2-3 times daily for 5-7 days, while oral antibiotics should be reserved for extensive disease. 1

Clinical Presentation

Nonbullous Impetigo (70% of cases)

  • Caused by Staphylococcus aureus or Streptococcus pyogenes 1, 2
  • Characterized by:
    • Honey-colored crusts on face and extremities 2
    • Initially appears as small red macules
    • Progresses to vesicles that rupture and form golden-yellow crusts
    • Commonly affects exposed areas (face, arms, legs)
    • Highly contagious 3

Bullous Impetigo (30% of cases)

  • Caused exclusively by S. aureus 2
  • Characterized by:
    • Large, flaccid bullae (fluid-filled blisters)
    • More likely to affect intertriginous areas 2
    • Fragile vesicles that rupture easily
    • Thin, varnish-like crust after rupture
    • Most common in children under 5 years, particularly neonates 4

Diagnostic Approach

  • Diagnosis is primarily clinical based on characteristic appearance 3, 2
  • Bacterial culture may be obtained from active lesions to:
    • Identify causative organism
    • Determine antibiotic sensitivities
    • Guide therapy in recalcitrant cases 1

Treatment Guidelines

Localized Impetigo

  • First-line: Topical mupirocin 2% ointment

    • Apply to affected areas 2-3 times daily for 5-7 days 1
    • Clinical efficacy rates of 71-93% 5
    • FDA-approved for impetigo due to S. aureus and S. pyogenes 5
    • Superior to placebo with pathogen eradication rates of 94% 5
  • Alternative topical options:

    • Retapamulin: No resistance reported yet 6
    • Fusidic acid: Similar efficacy to mupirocin 1, 2

Extensive Impetigo

  • Oral antibiotics recommended for widespread infection 1, 3

  • First-line options:

    • For MSSA: Dicloxacillin or cephalexin 1
    • For suspected/confirmed MRSA: Doxycycline, clindamycin, or trimethoprim-sulfamethoxazole 1
    • Standard duration: 7 days 1
  • Important considerations:

    • Avoid doxycycline in children under 8 years 1
    • Adjust dosing by weight for children 1
    • Oral penicillin V is seldom effective 3, 2
    • Amoxicillin-clavulanate: 875/125 mg twice daily for 7 days 1
    • Clindamycin: 300 mg three times daily for 7 days 1

Treatment Efficacy Comparison

  • Topical mupirocin is slightly superior to oral erythromycin (RR 1.07) 6
  • Mupirocin and fusidic acid have similar efficacy (RR 1.03) 6
  • Topical antibiotics are superior to disinfectants (RR 1.15) 6
  • Erythromycin is superior to penicillin (RR 1.29) 6

Common Pitfalls and Considerations

  • Failing to consider MRSA in recalcitrant cases 1
  • Using penicillin, which is inferior to other antibiotics 1, 6
  • Inadequate treatment duration 1
  • Relying solely on topical therapy for extensive disease 1
  • Not addressing underlying conditions predisposing to recurrent infection 1
  • Topical disinfectants are inferior to antibiotics and should not be used 3, 6

Prevention and Control

  • Good personal hygiene practices:

    • Regular handwashing
    • Keeping draining wounds covered
    • Avoiding sharing personal items 1
    • Using separate towels and linens 1
  • For recurrent infections:

    • Consider 5-day decolonization regimen with intranasal mupirocin, daily chlorhexidine washes, and decontamination of personal items 1
    • Evaluate for underlying immunodeficiency if recurrence happens more than 3 times 1
    • Prophylactic antibiotics may be considered for frequent recurrences (3-4 episodes per year) 1

Expected Outcomes

  • Resolution typically occurs within 7-10 days of starting appropriate treatment 1
  • Clinical response should be evident within 48-72 hours 1
  • Consider alternative antibiotics if no improvement within 3-5 days 1
  • Complications are rare, with poststreptococcal glomerulonephritis being the most serious 1, 2, 7

References

Guideline

Antibiotic Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Impetigo: diagnosis and treatment.

American family physician, 2014

Research

Diagnosis and treatment of impetigo.

American family physician, 2007

Research

Interventions for impetigo.

The Cochrane database of systematic reviews, 2012

Research

Impetigo.

Advanced emergency nursing journal, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.